Jazz Pharmaceuticals Director Jennifer E. Cook Files Form 144 to Sell $857K in Common Stock

Summary of Proposed Insider Sale

• Filer: Jennifer E. Cook, Director of Jazz Pharmaceuticals plc.
• Transaction: Notice of proposed sale under Rule 144 for 3,507 common shares.
• Estimated Value: $857,602.00 (~$244.54 per share based on market value provided).
• Date of Proposed Sale: August 31, 2026.
• Origin of Shares: Acquired on August 28, 2026, through restricted stock vesting as part of equity compensation.
• Broker: E*TRADE Financial Corporation.
• Past 3 Months Activity: Filer reported no other securities sold during the past three months.

Significance

The transaction represents a standard disposition of recently vested equity compensation by an independent director, resulting in low overall market or sentiment impact.